Showing results (1951-1960 of 2,134) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|November 10, 2005
Comparative bioavailability of two oral formulations of ranitidineFrancisco J Flores-Murrieta, Alejandra Toledo, Miriam del Carmen Carrasco-Portugal, et al.Biopharmaceutics & Drug Disposition|November 10, 2005
In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acidYuji Mano, Takashi Usui, Hidetaka KamimuraBiopharmaceutics & Drug Disposition|October 31, 2009
In vitro-in vivo correlation for nevirapine extended release tabletsSreeraj Macha, Chan-Loi Yong, Todd Darrington, et al.Biopharmaceutics & Drug Disposition|April 25, 2019
Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed miceA Joseph Bloom, Pramod Upadhyaya, Evan D KharaschBiopharmaceutics & Drug Disposition|October 9, 2018
Co-administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1Liping Li, Hongmei Lei, Wei Wang, et al.Biopharmaceutics & Drug Disposition|October 1, 1985
Electron-capture gas chromatographic determination of loprazolam in plasma and a pharmacokinetic applicationF A Levasseur, G Caillé, R Elie, et al.Biopharmaceutics & Drug Disposition|June 6, 2018
Pharmacokinetics and Pharmacodynamics of Curcumin in regulating anti-inflammatory and epigenetic gene expressionSarandeep S S Boyanapalli, Ying Huang, Zhengyuan Su, et al.Biopharmaceutics & Drug Disposition|September 27, 2017
Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulationAkihiko Goto, Yoshihiko Tagawa, Yuu Moriya, et al.Biopharmaceutics & Drug Disposition|December 29, 2018
Association between the pharmacokinetics of capecitabine and the plasma dihydrouracil to uracil ratio in rat: A surrogate biomarker for dihydropyrimidine dehydrogenase activityShinji Kobuchi, Mako Akutagawa, Yukako Ito, et al.Biopharmaceutics & Drug Disposition|June 24, 2022
Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stageTaisuke Kawamura, Mako Ichikawa, Jo Hatogai, et al.Pageof 214